Skip to main content
PTC Therapeutics, Inc. (PTCT)
NASDAQ: PTCT · Real-Time Price · USD
42.50
+2.02 (4.99%)
Oct 29, 2024, 4:00 PM EDT - Market closed

PTC Therapeutics Revenue

PTC Therapeutics had revenue of $186.70M in the quarter ending June 30, 2024, a decrease of -12.68%. This brings the company's revenue in the last twelve months to $900.45M, up 9.98% year-over-year. In the year 2023, PTC Therapeutics had annual revenue of $937.82M with 34.20% growth.

Revenue (ttm)
$900.45M
Revenue Growth
+9.98%
P/S Ratio
3.59
Revenue / Employee
$853,511
Employees
1,055
Market Cap
3.27B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023937.82M239.02M34.20%
Dec 31, 2022698.80M160.21M29.75%
Dec 31, 2021538.59M157.83M41.45%
Dec 31, 2020380.77M73.79M24.04%
Dec 31, 2019306.98M42.25M15.96%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Envista Holdings 2.53B
Amedisys 2.29B
Neogen 912.20M
Zai Lab 322.71M
Rhythm Pharmaceuticals 101.78M
Kymera Therapeutics 88.55M
Iovance Biotherapeutics 32.77M
Revenue Rankings

PTCT News

More News